Why Is Rocket Pharmaceuticals (RCKT) Down 4.8% Since Last Earnings Report? [Yahoo! Finance]
Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) had its "outperform" rating re-affirmed by analysts at William Blair.
Rocket Pharmaceuticals (NASDAQ:RCKT) Is In A Good Position To Deliver On Growth Plans [Yahoo! Finance]
EC grants orphan medicinal product status to Rocket's RP-A601 [Yahoo! Finance]
Rocket Pharmaceuticals Receives Orphan Medicinal Product Designation from the European Commission for RP-A601 for PKP2 Arrhythmogenic Cardiomyopathy [Yahoo! Finance]